수젠텍

253840KOSDAQ의료용품 및 기타 의약 관련제품 제조업

47.8 / 100

Reference Date: 2026-07-24

Financial Score16.0 / 40

News Sentiment15.8 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is undervalued vs. peers but the high debt ratio poses financial risk. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

SuneTech develops and commercializes diagnostic technologies and products in multiplex immuno blot, point-of-care testing (POCT), digital healthcare, and health & beauty sectors, leveraging BIO/NANO/IT/A.I convergence. The company is expanding into personalized healthcare services and FemTech, utilizing diagnostic data for customized health and beauty solutions such as functional foods and cosmetics.

Number of Employees

153people

Average Salary

49.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.184.0Point

PBR

0.89Industry Average 1.094.0Point

In line with industry avg

ROE

-27.03Industry Average -4.893.5Point

5.5x industry avg (excellent)

Debt Ratio

21.45Industry Average 6.860.0Point

3.1x industry avg (risky)

Trend 2023~20254.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲17.4% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲8.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -18.5% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 2Neutral 3Negative 0Average Sentiment Score 63

Neutral
서울창조경제혁신센터·씨엔티테크, ‘2026 펨테크 플러스’ 성료
행사는 펨테크 산업의 가치 확산과 생태계 조성에 초점을 맞추었으나, 직접적인 수젠텍 주식 영향은 제한적입니다.
Positive
“‘펨테크 육성 위해 조 단위 펀드 필요”
정부 주도의 펨테크 산업 육성을 위한 대규모 펀드 조성 계획 발표로 수젠텍을 포함한 관련 기업들의 성장 기대감 증가.
Neutral
씨엔티테크·서울창조경제혁신센터, 23일'펨테크 플러스'개최…국내 ...
Event highlights collaboration between 씨엔티테크 and 서울창조경제혁신센터 for 펨테크 industry growth but lacks direct impact on 수젠텍 stock.

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 4,090Won52-week high 7,86052-week low 3,620

1-month return3.0Point

1m 0.49% (flat)

Volume trend2.0Point

Volume flat

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-20
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-20